Stage IV marginal zone B-cell lymphoma--prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study (Q57227045)
Jump to navigation
Jump to search
scientific article published on 01 November 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Stage IV marginal zone B-cell lymphoma--prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study |
scientific article published on 01 November 2010 |
Statements
Stage IV marginal zone B-cell lymphoma--prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study (English)
Hyeon Seok Eom
Sung Yong Oh
Won Seog Kim
Jin Seok Kim
Seok Jin Kim
Suee Lee
Dae Ho Lee
Jong-Ho Won
In Gyu Hwang
Min Kyoung Kim
Soon Il Lee
Yee Soo Chae
Deok-Hwan Yang
Hye Jin Kang
Chul Won Choi
Jinny Park
Hyo Jung Kim
Ho Sup Lee
Gyeong-Won Lee
Jae-Yong Kwak
1 November 2010